) UPCI's laboratory Animal Facility is located in the Biomedical Science Tower and is an AAALAC-approved facility. It is managed by the Department of Laboratory Animal Resources, University of Pittsburgh, headed by Paul H. Bramson, D.V.M. The Facility, which opened in 1991, was developed in response to the needs of the UPCI and other investigators whose research requires virus-free animals for their research. Many of the studies of the UPCI investigators concern the immunologic responses to tumors and often require long-term maintenance of mice and rats, including nude mice, for tumor development and experimental manipulations. Therefore, it is essential that the animals have a stable environmental background, without interruption by periodic and unpredictable microbial infections. Veterinary medical support staff is provided in conjunction with the University's Laboratory Animal Resources. The overall veterinary staff includes five veterinarians, one board certified veterinary pathologist, five animal health technicians and a histopathology technician. Most histopathology and microbiology can be performed in-house. A stringent program for monitoring the health and potential exposure to infectious agents of the animals housed has been implemented. Sentinel animals are placed in each animal room and are sampled quarterly to assess background pathology and viral antibody profiles. In addition to the direct supervision of the facility by Dr. Bramson and the Facility supervisor, policies involving other issues are dealt with by the Laboratory Animal Facility Committee, chaired by Dr. Candace S. Johnson, Deputy Director for Basic Research, and comprised of all investigators who house animals in the facility. This committee has formulated the Policies Regulating Use of the BST Animal Facility, and meets as needed, to discuss problems or issues related to the facility. Policies have been written to cover the purchasing, sources and health monitoring of the laboratory animals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA047904-12
Application #
6212126
Study Section
Subcommittee G - Education (NCI)
Project Start
1988-08-01
Project End
2004-07-30
Budget Start
Budget End
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Zahorchak, Alan F; Macedo, Camila; Hamm, David E et al. (2018) High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation. Cell Immunol 323:9-18
Rogers, Meredith C; Lamens, Kristina D; Shafagati, Nazly et al. (2018) CD4+ Regulatory T Cells Exert Differential Functions during Early and Late Stages of the Immune Response to Respiratory Viruses. J Immunol 201:1253-1266
Chen, Ruochan; Zhu, Shan; Fan, Xue-Gong et al. (2018) High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis. Hepatology 67:1823-1841
Jing, Y; Nguyen, M M; Wang, D et al. (2018) DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor. Oncogene 37:638-650
Singh, Krishna B; Ji, Xinhua; Singh, Shivendra V (2018) Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer. Mol Cancer Ther 17:2079-2090
Butterfield, Lisa H (2018) The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review. Semin Cancer Biol 52:12-15
Gao, Ying; Tan, Jun; Jin, Jingyi et al. (2018) SIRT6 facilitates directional telomere movement upon oxidative damage. Sci Rep 8:5407
Krishnamurthy, Anuradha; Dasari, Arvind; Noonan, Anne M et al. (2018) Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer. Cancer Res 78:5398-5407
Santos, Patricia M; Butterfield, Lisa H (2018) Next Steps for Immune Checkpoints in Hepatocellular Carcinoma. Gastroenterology 155:1684-1686
Liu, Zuqiang; Ge, Yan; Wang, Haiyan et al. (2018) Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2. Nat Commun 9:4682

Showing the most recent 10 out of 1187 publications